Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply

Aliment Pharmacol Ther. 2022 Sep;56(5):894-895. doi: 10.1111/apt.17160.

Authors

Vivek C Goodoory^{1

2}, Cho Ee Ng³, Christopher J Black^{1

2}, Alexander C Ford^{1

2}

Affiliations

¹ Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
² Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
³ County Durham and Darlington NHS Foundation Trust, Durham, UK.

PMID: 35934862
DOI: 10.1111/apt.17160

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Diarrhea
Humans
Irritable Bowel Syndrome* / drug therapy